These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7524313)

  • 41. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
    Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
    J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
    Watanabe I; Sakai I; Matsumoto I
    Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
    Miniero R; Pastore G; Saracco P; Messina M; Lange MM; Fiandino G; Iannacci L; Madon E
    Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
    Rodeghiero F; Castaman G; Dini E
    Thromb Res; 1990 Jan; 57(1):31-8. PubMed ID: 2300923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapy.
    Barbui T; Rodeghiero F; Meli S; Dini E
    Acta Haematol; 1983; 69(3):188-91. PubMed ID: 6404103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [L-asparaginase, antithrombin III deficiency and thromboses (author's transl)].
    Bordigoni P; Briquel E; Olive D
    Arch Fr Pediatr; 1981 Nov; 38(9):653-5. PubMed ID: 6949499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia.
    Homans AC; Rybak ME; Baglini RL; Tiarks C; Steiner ME; Forman EN
    J Clin Oncol; 1987 May; 5(5):811-7. PubMed ID: 3572467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia.
    Bushman JE; Palmieri D; Whinna HC; Church FC
    Leuk Res; 2000 Jul; 24(7):559-65. PubMed ID: 10867129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.
    Ishihara T; Nogami K; Ochi S; Ishida T; Kosaka Y; Sawada A; Inoue M; Osone S; Imamura T; Hosoi H; Shima M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28016. PubMed ID: 31556233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in coagulation and fibrinolysis in childhood acute lymphoblastic leukaemia re-induction therapy using three different asparaginase preparations.
    Nowak-Göttl U; Ahlke E; Klösel K; Jürgens H; Boos J
    Eur J Pediatr; 1997 Nov; 156(11):848-50. PubMed ID: 9392397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
    Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
    Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
    Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
    Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
    Merlen C; Bonnefoy A; Wagner E; Dedeken L; Leclerc JM; Laverdière C; Rivard GE
    Pediatr Blood Cancer; 2015 Aug; 62(8):1381-7. PubMed ID: 25820776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation.
    Nowak-Göttl U; Ahlke E; Schulze-Westhoff P; Boos J
    Br J Haematol; 1996 Oct; 95(1):123-6. PubMed ID: 8857948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma.
    Kucuk O; Kwaan HC; Gunnar W; Vazquez RM
    Cancer; 1985 Feb; 55(4):702-6. PubMed ID: 3855365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced thrombin generation and depressed anticoagulant function in children with pneumonia.
    Långström S; Peltola V; Petäjä J; Ruuskanen O; Heikinheimo M
    Acta Paediatr; 2012 Sep; 101(9):919-23. PubMed ID: 22646857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors].
    Xu LW; Wei XL; Wei YQ; Hao XX; Zhou QJ; Feng R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):30-5. PubMed ID: 26913389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.